Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: A potential nutrient-nutrient interaction

Cancer Causes and Control

Volumn 23, Issue 9, 2012, Pages 1557-1565

  Cheng, Ting Yuan David ^a,b   Neuhouser, Marian L ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Lung cancer; Retinol; Retinyl esters; Serum 25 hydroxyvitamin D; The Third National Health and Nutrition Examination Survey (NHANES III)

Indexed keywords

25 HYDROXYVITAMIN D; BETA CAROTENE; BIOLOGICAL MARKER; RETINOL; RETINOL ESTER;

ADULT; ARTICLE; CANCER MORTALITY; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADIOIMMUNOASSAY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; BETA CAROTENE; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; FOOD-DRUG INTERACTIONS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; UNITED STATES; VITAMIN A; VITAMIN D;

EID: 84864879884     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0033-8     Document Type: Article

References (41)

1. Samet JM, Avila-Tang E, Boffetta P et al (2009) Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res 15:5626-5645
2. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684-700
3. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW (2008) Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 181:7090-7099 Baltimore, Md.: 1950
4. Menezes RJ, Cheney RT, Husain Aet al (2008) VitaminDreceptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiol Biomarkers Prev 17:1104-1110
5. Turner A, McGowan L, Millen A, et al. (2012) Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology. Eur Respir J. doi:10.1183/09031936.00002912
6. Parise RA, Egorin MJ, Kanterewicz B et al (2006) CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. Int J Cancer 119:1819-1828
7. Kim B, Lee HJ, Choi HY et al (2007) Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Cancer Res 67:7431-7438
8. Chen G, Kim SH, King AN et al (2011) CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma. Clin Cancer Res 17:817-826
9. Ramnath N, Kim S, Christensen PJ (2011) Vitamin D and lung cancer. Expert Rev Respir Med 5:305-309
10. Haussler MR, Haussler CA, Jurutka PW, et al. (1997) The vitamin D hormone and its nuclear receptor: molecular actions and disease states. The Journal of Endocrinology. 154 (Suppl): S57-73-S57-73
11. Zou A, Elgort MG, Allegretto EA (1997) Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3. J Biol Chem 272:19027-19034
12. Arnhold T, Tzimas G, Wittfoht W, Plonait S, Nau H. (1996) Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro- retinol in human plasma after liver consumption. Life Sci 59: PL169-77
13. Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL (2007) Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 165:1178-1186
14. Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer 102:1422-1427
15. Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D (2011) Serum 25-hydroxyvitamin d and risk of lung cancer in male smokers: a nested case-control study. PLoS One 6:e20796
16. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI (2010) Serum vitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res 70:8587-8597
17. Freedman DM, Looker AC, Chang S-C, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99:1594-1602
18. Kilkkinen A, Knekt P, Heliövaara M et al (2008) Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer Epidemiol Biomarkers Prev 17:3274-3278
19. Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451-459
20. Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, Oxford
21. Mannino DM, Gagnon RC, Petty TL, Lydick E (2000) Obstructive lung disease and low lung function in adults in the United States: data from the national health and nutrition examination survey, 1988-1994. Arch Intern Med 160:1683-1689
22. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771-777
23. Gunter EW, Lewis BG, Koncikowski SM (1996) Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994
24. Cheung YB (2007) A modified least-squares regression approach to the estimation of risk difference. Am J Epidemiol 166: 1337-1344
25. Knoke JD, Burns DM, Thun MJ (2008) The change in excess risk of lung cancer attributable to smoking following smoking cessation: an examination of different analytic approaches using CPS-I data. Cancer Causes Control 19:207-219
26. Ebbert JO, Yang P, Vachon CM et al (2003) Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 21:921-926
27. Tong L, Spitz MR, Fueger JJ, Amos CA (1996) Lung carcinoma in former smokers. Cancer 78:1004-1010
28. Ballew C, Galuska D, Gillespie C (2001) High serum retinyl esters are not associated with reduced bone mineral density in the third national health and nutrition examination survey, 1988-1994. J Bone Miner Res 16:2306-2312
29. IOM (Institute of Medicine) (2011) Overview of Vitamin D. Dietary Reference Intake for Calcium and Vitamin D. Washington, DC: The National Academics Press
30. Park YK, Kim I, Yetley EA (1991) Characteristics of vitamin and mineral supplement products in the United States. Am J Clin Nutr 54:750-759
31. Bailey RL, Gahche JJ, Lentino CV et al (2011) Dietary supplement use in the United States, 2003-2006. J Nutr 141:261-266
32. Higashimoto Y, Ohata M, Nishio K et al (1996) 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line. Anticancer Res 16:2653-2659
33. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS (1999) 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res 59:2644-2649
34. Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS (1997) Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res 57:3759-3764
35. Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T (2005) 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 26:1044-1054
36. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE (2000) 1 Alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 87:214-220
37. Bao BY, Yao J, Lee YF (2006) 1 Alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 27:1883-1893
38. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359:1367-1380
39. Zhou W, Suk R, Liu G et al (2005) Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 14:2303-2309
40. Millen AE, Bodnar LM (2008) Vitamin D assessment in population-based studies: a review of the issues. Am J Clin Nutr 87:1102S-1105S
41. Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP (2010) Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 19:927-931